LGALS3 and periodontitis: A previous study investigated the Gal-3 levels in the gingival crevicular fluid (GCF) in periodontitis, gingivitis, and healthy individuals and found that Gal-3 is a potential biomarker for gingival inflammation; periodontal therapy efficiently reduced the GCF Gal-3 levels [17].